AJMC October 17, 2024
Key Takeaways
- Artificial intelligence (AI) can accelerate drug development, reduce costs, and improve treatment efficacy, but faces challenges like data quality and regulatory hurdles.
- Over 900 FDA-approved AI-enabled devices exist, with companies like Johnson & Johnson and AbbVie leveraging AI for drug discovery.
- AI market growth is projected to increase significantly, with advancements in protein folding and molecular interaction predictions.
- Addressing limitations of AI is crucial for revolutionizing drug discovery and improving patient outcomes.
Artificial intelligence can revolutionize drug discovery by expediting development, reducing costs, and improving treatment options, but addressing its limitations is crucial for future success.
The implementation of artificial intelligence (AI) throughout the drug discovery process can assist with faster drug developments, cost savings reductions,...
Today's Sponsors
Today's Sponsor